LPL Financial
LPCN icon

LPL Financial’s Lipocine LPCN Stock Holding History

LPL Financial’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,324
Closed -$18K – 4640
2023
Q1 		$18K Sell
3,324
-294
-8% -$2.27K ﹤0.01% 4421
2022
Q4 		$24.5K Sell
3,618
-73
-2% -$532 ﹤0.01% 4348
2022
Q3 		$28K Hold
3,691
– – ﹤0.01% 4294
2022
Q2 		$50K Sell
3,691
-441
-11% -$6.87K ﹤0.01% 4234
2022
Q1 		$96K Buy
4,132
+441
+12% +$9.23K ﹤0.01% 3984
2021
Q4 		$62K Hold
3,691
– – ﹤0.01% 4206
2021
Q3 		$68K Hold
3,691
– – ﹤0.01% 4199
2021
Q2 		$88K Buy
3,691
+1,176
+47% +$27.7K ﹤0.01% 4082
2021
Q1 		$65K Buy
2,515
+30
+1% +$866 ﹤0.01% 3972
2020
Q4 		$57K Hold
2,485
– – ﹤0.01% 3722
2020
Q3 		$60K Hold
2,485
– – ﹤0.01% 3422
2020
Q2 		$53K Buy
+2,485
New +$32.2K ﹤0.01% 3348

Other funds holding LPCN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LPL Financial's LPCN Position: Q2 2023 in Review

LPL Financial sold out of Lipocine (LPCN) in Q2 2023, closing a stake of 3,324 shares — an estimated $18K sold.

LPL Financial first reported a position in LPCN in Q2 2020 and held it in 12 quarters. The position peaked at $96K in Q1 2022. 24 funds tracked by Wall St. Rank hold LPCN as of Q2 2023.

  • LPL Financial reported no remaining Lipocine position as of Q2 2023 after selling out during the quarter.
  • LPL Financial sold 3,324 Lipocine shares in Q2 2023, an estimated $18K.
  • LPL Financial first reported a position in Lipocine in Q2 2020 and held it in 12 quarters.
  • LPL Financial's Lipocine position peaked at $96K in Q1 2022.
  • 24 funds tracked by Wall St. Rank held Lipocine as of Q2 2023.

Based on LPL Financial's 13F filing for Q2 2023, filed 31 Jul 2023.